Skip to main content
Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
1.941
+0.021 (1.09%)
At close: Nov 13, 2026, 4:00 PM EST
1.920
-0.021 (-1.08%)
After-hours: Nov 13, 2026, 7:30 PM EST

Propanc Biopharma Ratios and Metrics

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
13480--
Market Cap Growth
-88.54%-92.91%11605.48%---
Enterprise Value
15491--
Last Close Price
1.9415.001037.5018712.572020958.0836750000.00

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PB Ratio
0.270.363.47-0.11--
P/TBV Ratio
0.170.363.47---

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
0.060.050.12-0.25-0.17-0.34
Net Debt / Equity Ratio
0.02-0.030.12-0.24-0.17-0.34
Net Debt / EBITDA Ratio
-0.010.02-0.03-0.60-0.30-0.52
Net Debt / FCF Ratio
-0.030.06-4.23-0.99-0.48-0.72
Quick Ratio
0.080.250.000.010.000.00
Current Ratio
2.472.551.500.010.010.01
Return on Equity (ROE)
-211.03%-161.86%-1163.67%---
Return on Assets (ROA)
-97.54%-70.14%-363.36%-1447.01%-1564.19%-2626.42%
Return on Capital Employed (ROCE)
-311.60%-192.90%-407.60%41.30%57.30%66.80%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Nov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-4399.20%-551.94%-122.28%-442.22%--
FCF Yield
-465.19%-166.42%-0.84%-227.15%--
Buyback Yield / Dilution
-878.12%-607.94%----